Significance of BRAF Kinase Inhibitors for Melanoma Treatment: From Bench to Bedside

Taku Fujimura(Université Paris Cité), Setsuya Aiba(Tohoku University)
Cancers
September 11, 2019
Cited by 28


Related Papers